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SS6.
Preoperative Functional Status Predicts Poor Perioperative Outcomes
After Infrainguinal Bypass Surgery: an NSQIP Report
Robert S Crawford, Christopher J Abularrage, Mark F Conrad, Todd R.
Lancaster, Michael T. Watkins, Richard P. Cambria, Glenn M. LaMuraglia.
Massachusetts General Hospital, Boston, MA
Objective: Infrainguinal surgical bypass (BPG) is the gold-standard for
lower extremity revascularization despite significant 30-day morbidity and
mortality (MM). The goal of this study is to determine the ability of
pre-operative functional status to predict perioperative MM and thus iden-
tify patients who may be unsuitable for BPG.
Methods: All BPG data between 1/1/05-12/31/07 from the pro-
spective NSQIP database was analyzed. The study end-point was 30-day
MM. Patients were stratified by preoperative functional status: independent
(IND) vs. dependent (DEP), defined as requiring assistance in performing
activities of daily living. Associated patient demographic/clinical data were
analyzed using univariate and multivariate methods with the construction of
high risk composites.
Results: There were 5639 BPG patients (4600 (81.6%) IND and 1039
(18.4%) DEP). DEP patients were significantly older (71.6  11.8 vs. 66.8
 11.8 years; p0.0001), had more COPD (16.7 vs. 11.4%; p0.0001),
diabetes (54.2 vs. 40.7%; p0.0001), current dialysis (16.4 vs. 5.6%;
p0.0001), and critical limb ischemia (64.6 vs. 44%; p0.0001). DEP
patients had a higher incidence of death (6.1 vs. 1.5%; p0.0001) and major
complications (30.3 vs. 14.2%; p0.0001).DEP was a multivariate indepen-
dent predictor of death (2.3[1.6-3.4]; p0.0001), major complications
(2.0[1.7-2.4]; p0.0001) major systemic complications (2.5[1.9-3.2];
p0.0001) and major operative site complications (1.6 [1.4-1.9];
p0.0001). When combined with DEP, there were multiple variables that
contributed to high-risk composites, e.g., the successive addition of 
hemodyalisis,  emergency surgery and  age  80 years increased the
death rate 13-, 38- and 97-times respectively. For major complications, the
successive addition of  emergency surgery,  Cr1.8 and  rest pain
increased the risk 5-, 7- and 11-times that of baseline.
Conclusion: Pre-operative DEP is a significant surrogate for comor-
bidities in addition to being an independent predictor of all major negative
30-day outcomes in BPG patients. Furthermore, when combined in high-
risk composites with specific preoperative clinical variables, DEP is associ-
ated with prohibitive MM, thereby identifying patient cohorts that can be
considered unsuitable for BPG.
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Antioxidant Therapy Reverses Impaired Graft Healing in Hypercho-
lesterolemic Rabbits
Michael A Rosenbaum, Keiko Miyazaki, Scott M Colles, Linda M Graham.
Cleveland Clinic Foundation, Cleveland, OH
Objective: Limited endothelial cell coverage and anastomotic intimal
hyperplasia contribute to thrombosis and failure of prosthetic grafts. Lipid
accumulation and lipid oxidation are associated with decreased endothelial
cell migration and intimal hyperplasia. The goal of this study was to assess
the ability of antioxidants to improve graft healing under hypercholester-
olemic conditions.
Methods: Rabbits were placed on one of four diets: chow plus N-ace-
tylcysteine, chow plus probucol, chow with 1% cholesterol plus N-acetylcys-
teine, or chow with 1% cholesterol plus probucol. After two weeks, 12 cm
long, 4 mm internal diameter expanded polytetrafluoroethylene grafts were
implanted in the abdominal aorta. Six weeks after implantation, the grafts
were removed and analyzed for cholesterol content, endothelial cell cover-
age, anastomotic intimal thickness, and the cellular composition of the
neointima. Plasma samples were obtained to assess systemic oxidative stress
levels. The data was compared with previously reported data from animals on
a chow and chow plus 1% cholesterol diet.
Results: Prosthetic grafts from rabbits on a 1% cholesterol diet had
significantly greater anastomotic intimal thickening and lower endothelial
cell coverage than grafts from rabbits on a chow diet. Antioxidant therapy
decreased global oxidative stress in hypercholesterolemic rabbits. In rabbits
on the 1% cholesterol diet, N-acetylcysteine decreased intimal hyperplasiaatthe proximal anastomosis by 29% and significantly increased graft endo-
thelial cell coverage from 46% to 71% (P  .03). Similarly, probucol
decreased intimal hyperplasia by 43% and increased graft endothelial cell
coverage to 53% in hypercholesterolemic rabbits.
Conclusions: Endothelialization of prosthetic grafts is significantly
reduced and anastomotic intimal hyperplasia is significantly increased in
rabbits on a high cholesterol diet. Treatment with antioxidants improves
endothelial cell coverage and decreases intimal hyperplasia. Reducing oxi-
dative stress may promote patency of prosthetic grafts.
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Renal Parenchymal Preservation After Percutaneous Renal Angio-
plasty And Stenting.
Mark G Davies, Jean Bismuth, Joseph J Naoum, Imran T Mouhiddin, Eric
K Peden, Alan B Lumsden. Methodist Debakey Heart and Vascular Center,
Houston, TX
Objective:The intent of endovascular therapy for symptomatic athero-
sclerotic renal artery stenosis (ARAS) is to preserve parenchyma and avoid
renal-related morbidity.
Methods: We performed a retrospective analysis of records from
patients who underwent endovascular intervention for ARAS and were
followed by duplex ultrasound between 1990 and 2008. Renal volume (in
cm3) was estimated in all patients as renal length (cm) x renal width (cm) x
renal depth (cm)x0.5. The normal renal volume was calculated as 2 x body
weight (kg) in cm3. Failure of preservation was considered to be a persistent
5% decrease in volume. Clinical benefit defined as freedom from renal-
related morbidity (increase in persistent creatinine 20% of baseline, pro-
gression to hemodialysis, death from renal-related causes) was calculated.
Results: 592 renal artery interventions were performed. 188 kidneys
suffered parenchymal loss (5%) with an actuarial parenchymal loss rate of
291% at 5 years respectively. There were no significant differences in age,
gender, starting renal volume or kidney size (Table 1). However, patients
with parenchymal loss had lower eGFR, higher resistive index and worse
glomerulosclerosis grade then those not suffering parenchymal loss (Table
1). Parenchymal loss was associated with significantly worse survival and
freedom from renal-related morbidity with increased numbers progressing
to dialysis.
Table 1
No parenchymal
loss
Parenchymal
loss p-value
Gender (%
female)
55 49 ns
Age (years) * 70  11 719 ns
eGFR (ml/min/
1.73m2)
5324 4524 0.05
Starting Renal
Volume (% of
normal) *
9019 9017 ns
Renal size (cm)* 10.21.4 10.31.2 ns
Resistive Index
(RI)*
0.730.10 0.870.9 0.05
Glomerulosclerosis
Grade (GSG)
1.300.49 1.430.55 0.05
Survival (%)
†
882 264 0.001
Freedom from
renal-related
morbidity (%)
†
822 705 0.05
New onset
Hemodialysis
(%)
7 17 0.05
*MeanSD.
†MeanSEM at five years follow up.
